Skip to main content

Cel Sci Corp

CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000725363

In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Cel Sci Corp changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CVM: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders3540+5
Shares871.6K742.2K−129.4K (−14.8%)
Value$8.01M$3.90M−$4.11M (−51.3%)

New holders (10)

Institutions that held Cel Sci Corp at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CVM in Q4 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC15,707$82.6K0.00%
Renaissance Technologies LLC15,406$81.0K0.00%
XTX Topco Ltd12,507$65.8K0.00%
Citadel Advisors LLC11,806$62.1K0.00%
HRT Financial LP11,538$60.0K0.00%
HighTower Advisors, LLC10,000$52.6K0.00%
Hilton Head Capital Partners, LLC450$2.37K0.00%
Fortitude Family Office, LLC75$3950.00%
SageView Advisory Group, LLC6$320.00%
Navalign, LLC3$160.00%

Sold out (5)

Institutions that held Cel Sci Corp at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CVM in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Group One Trading, L.P.111$1.02K
City State Bank67$616
GWM Advisors LLC26$239
Advisory Services Network, LLC9$83
Darwin Advisors, LLC1$9